Your Passport to the Newsiverse
In the crosshairs of the latest controversy on whether a drug is spurious or “not of standard quality” is the Indian patient. The pharma industry suffered a body blow recently after government agencies pulled up over 50 popular medicine brands. How do patients trust their medicines?
Habil Khorakiwala, founder and chairman, Wockhardt Synopsis Wockhardt’s Habil Khorakiwala has seen the most harrowing days. From a payment default to bond holders to troubled factories, Khorakiwala pulled the company out of its biggest crises. Now, just one drug, that is touted as the biggest breakthrough in antibiotics after penicillin, can bring him back in […]
Illustration by Sadhana Saxena via AI. Synopsis Advent, which merged Suven Pharma with Cohance Lifesciences in February, looks to take advantage of the China+1 wave and other geopolitical tailwinds. While the skills of its scientists give India an edge in pharma outsourcing, the scale of local contract manufacturers pales in front of global rivals from […]
India, home to the world’s largest low- and middle-income (LMIC) population, is now facing a weighty challenge — literally. It accounts for a staggering 15% of the global obesity burden, and by 2040, almost half of the Indian population is projected to be overweight or obese. The latest National Family Health Survey (NFHS-5) reveals a […]